Summary:Allogeneic cord blood transplantation (CBT), especially from unrelated donors, is being increasingly used for treating paediatric patients with both malignant and nonmalignant disorders. Recent clinical and experimental evidence suggests that human cord blood mononuclear cells (CBMC) may acquire in utero a state of tolerance towards non-inherited maternal antigens (NIMA). In order to better define this phenomenon, we measured, by means of a limiting dilution assay (LDA), the frequency of NIMA-specific CTL precursors ( Over the past decade, allogeneic cord blood transplantation (CBT) from both related and unrelated donors has been used increasingly for the treatment of paediatric patients with both malignant and non-malignant disorders. 1-4 Previously published results demonstrate that, at least when the donor is a compatible relative, CBT recipients experience a